NYSE : NUS

Nu Skin Enterprises, Inc.

$5.17 USD

-$0.32 (-5.83%)

Volume
799.68K
Average Volume
623.32K
Market Capitalization
$251.01M
P/E Ratio
-1.16
Dividend Yield
4.64%
Price Target
$11.00
Year High
$14.62
Year Low
$4.89
Day High
—
Day Low
—
Payout Ratio
-$0.05
Current Ratio
$1.98
Company Overview

NYSE

Ryan S. Napierski

Household & Personal Products

Consumer Defensive

NUS

2800

US

USD

https://www.nuskin.com

801 345 1000

67018T105

0001021561

Liquidity Metrics

0.49

1.98

1.24

0.74

-0.05

Sales & Valuation

$1.49B

0.18

0.46

23.28

0.22

Profitability

$3.18

$160.2M

-15.73%

-1.92%

-29.42%

-19.29%

P/E Metrics

-1.16

0.00

0.00

Analyst Price Target & Rating

$11.00

$11.00

$11.00

Buy

4/5

11 Analysts

-53.00%

Financial Health Scores

3.63

7/9

$265.89M

$1.38B

$582.71M

$79.11M

Key Metrics (TTM)

$345.5M

0.24

2.67

2.03

6.84%

6.08%

20.60%

15.60%

$20.48

135 days

Company Executives
Name Title
Steven J. Lund Co-Founder & Executive Chairman of the Board
Chayce David Clark Executive VP, COO & Chief Legal Officer
Ryan S. Napierski President, Chief Executive Officer & Director
Joe Sueper Senior Vice President & Chief Technology Officer
Justin Keisel Executive Vice President & President of Global Sales
Joseph Y. Chang Executive Vice President & Chief Scientific Officer
Blake Roney Founder
Hunt VP of Treasurer, Investor Relations & Admin Services
Sandra N. Tillotson Founder
Chelsea Lantz Interim Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other rel ... ated weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

2026-08-11 06:58:23

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Nu Skin Enterprises Q2 Earnings Call Highlights

2026-08-11 00:04:10

Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives.

Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates

2026-08-10 18:21:08

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.2 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.43 per share a year ago.

Nu Skin Enterprises Reports Second Quarter Results

2026-08-10 16:06:00

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results. Executive Summary Q2 2026 vs. Prior-year Quarter Revenue $320.1 million; (17.1)% (1.0)% FX impact or $(4.0) million Earnings Per Share (EPS) $(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43 Customers 660,037; (14)% Paid Affiliates 120,291; (8)% Sales Leaders 26,998; (9)% “We continue to make progress toward our long-term strategy with the continued.

Nu Skin Enterprises Announces Quarterly Dividend

2026-08-10 16:05:00

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on Sept. 9, 2026, to shareholders of record on Aug. 28, 2026. About Nu Skin Enterprises Inc. Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scien.

Head-To-Head Analysis: BioHarvest Sciences (NASDAQ:BHST) versus Nu Skin Enterprises (NYSE:NUS)

2026-08-04 01:59:07

Nu Skin Enterprises (NYSE: NUS - Get Free Report) and BioHarvest Sciences (NASDAQ: BHST - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Volatility and Risk Nu Skin

Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results

2026-07-21 16:18:00

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2026 results after the market closes on Monday, Aug. 10. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.

July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys

2026-07-11 06:01:57

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks meeting this ideal condition.

Frequently Asked Questions

What is the current Nu Skin Enterprises, Inc. (NUS) stock price?

Nu Skin Enterprises, Inc.(NYSE:NUS) stock price is $5.17 in the last trading session. During the trading session, NUS stock reached the peak price of $14.62 while $4.89 was the lowest point it dropped to. The percentage change in NUS stock occurred in the recent session was --5.83% while the dollar amount for the price change in NUS stock was -$0.32.

NUS's industry and sector of operation?

The NYSE listed NUS is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector.

Who are the executives of NUS?

Steven J. Lund | Co-Founder & Executive Chairman of the Board
Chayce David Clark | Executive VP, COO & Chief Legal Officer
Ryan S. Napierski | President, Chief Executive Officer & Director
Joe Sueper | Senior Vice President & Chief Technology Officer
Justin Keisel | Executive Vice President & President of Global Sales

How many employees does NUS have?

Number of NUS employees currently stands at 2800. NUS operates from 75 West Center Street, Provo, UT 84601, US.

Link for NUS official website?

Official Website of NUS is: https://www.nuskin.com

How do I contact NUS?

NUS could be contacted at phone #801 345 1000 and can also be accessed through its website. NUS operates from 75 West Center Street, Provo, UT 84601, US.

How many shares of NUS are traded daily?

The average number of NUS shares traded daily for last 3 months was 623.32K.

What is the market cap of NUS currently?

The market value of NUS currently stands at $251.01M with its latest stock price at $5.17